All Regulation articles – Page 12
-
Business
Two deadly chemical plant explosions in China
Dye factory incident kills 9 people, prompting detention of company officials, while a second plant explosion took 4 lives
-
Business
Pharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
Business
Chemicals industry roundup 2019
Focus turns to sustainability amid rising economic pressures and political uncertainty
-
Business
Former Braskem chief arrested in US for bribery
Ex-leader of Brazilian petrochemical firm allegedly helped divert $250m to a secret slush fund to bribe government officials and political parties
-
Business
From philanthropy to sustainability
Corporate Social Responsibility in the pharmaceutical and chemical industries is changing
-
-
Business
Former Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
Business
Nitrosamine contamination withdrawals spread to new drugs
After ranitidine recalls, EU regulators instruct companies to review all their products for potential impurities
-
Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
Business
Chemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
Opinion
Will Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
News
Concerns raised over ‘regrettable’ BPA substitutions
Research indicates chemicals used as alternatives to bisphenol A in polycarbonate plastics and epoxy resins aren’t always safer
-
News
Data manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Business
US ditches chlorpyrifos ban for food crops
Environmental Protection Agency says evidence of harm from food residues is insufficient
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
News
UK MPs criticise government inaction on harmful chemicals
A report calls for urgent changes to the way flame retardants and packaging additives are regulated
-
Business
China makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
Business
US finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
Business
Industry criticises proposed US asbestos ban
Outright ban would compromise chlorine supply and public health, claims trade body